Cost-effectiveness of specialized nursing interventions for patients with Parkinson*s disease
- Conditions
- Parkinson's disease and Parkinson's10028037
- Registration Number
- NL-OMON46561
- Lead Sponsor
- Radboud Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 240
1. Patients with idiopathic Parkinson's disease:
- that have sufficient knowledge of the Dutch language;
- that were 18 years old at the time of diagnosis;
- in all disease stages, regardless of disease severity or disease duration;
- who are currently not treated by a Parkinson's disease nurse specialist and who have not been treated by a Parkinson's disease nurse specialist in the past two years;
- who have a score of >=18 on the Mini-Mental State Examination (MMSE) and >=12 on the Frontal Assessment Battery (FAB).
1. Patients with a type of atypical parkinsonism caused by medication (e.g. neuroleptics), a metabolic disorder (e.g. Wilson's disease), encephalitis or a neurodegenerative disorder (e.g. MSA, PSP).
2. Patients with Parkinson's disease that live in a nursing home or another type of residential care facility (because the Parkinson's disease nurse specialist is not operational there).
3. Any other medical or psychiatric disorder that, in the opinion of the researcher, may compromise participation in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The co-primary outcome measures are:<br /><br><br /><br>- Quality of life measured with the Parkinson's Disease Questionnaire (PDQ-39).<br /><br>- Motor symptoms measured with the Movement Disorders Society-sponsored<br /><br>revision of the Unified Parkinson*s Disease Rating Scale part III (MDS-UPDRS<br /><br>part III)</p><br>
- Secondary Outcome Measures
Name Time Method